Botulinum toxin type A + Botulinum toxin type A + Placebo
Phase 2Completed 0 views this week 0 watching💤 Quiet
Interest: 32/100
32
Development Stage
✓
Pre-clinical✓
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Glabellar Frown Lines
Conditions
Glabellar Frown Lines
Trial Timeline
Mar 1, 2011 → Sep 1, 2011
NCT ID
NCT01333397About Botulinum toxin type A + Botulinum toxin type A + Placebo
Botulinum toxin type A + Botulinum toxin type A + Placebo is a phase 2 stage product being developed by Ipsen for Glabellar Frown Lines. The current trial status is completed. This product is registered under clinical trial identifier NCT01333397. Target conditions include Glabellar Frown Lines.
What happened to similar drugs?
0 of 11 similar drugs in Glabellar Frown Lines were approved
Approved (0) Terminated (0) Active (11)
Hype Score Breakdown
Clinical
12
Activity
8
Company
12
Novelty
0
Community
0
Clinical Trials (3)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01313299 | Phase 3 | Completed |
| NCT01261611 | Phase 3 | Completed |
| NCT01333397 | Phase 2 | Completed |
Competing Products
19 competing products in Glabellar Frown Lines
| Product | Company | Stage | Hype Score |
|---|---|---|---|
| AGN-151586 + BOTOX + Placebo | AbbVie | Phase 1 | 29 |
| Placebo + AGN-151586 | AbbVie | Phase 3 | 40 |
| AGN-151586 + Placebo | AbbVie | Phase 3 | 40 |
| AGN-151586 + OnabotulinumtoxinA + Placebo | AbbVie | Phase 1 | 29 |
| AGN-151586 + Placebo | AbbVie | Phase 3 | 40 |
| AGN-151586 | AbbVie | Phase 3 | 40 |
| AGN-151586 + Placebo | AbbVie | Phase 1 | 29 |
| Botulinum toxin type A + Botulinum toxin type A + Placebo + Placebo | Ipsen | Phase 3 | 37 |
| IPN10200 + Placebo | Ipsen | Phase 3 | 44 |
| Botulinum toxin type A + Placebo | Ipsen | Phase 3 | 37 |
| Botulinum toxin type A + Placebo | Ipsen | Phase 3 | 37 |
| IPN10200 + Placebo | Ipsen | Phase 3 | 44 |
| prabotulinumtoxinA | Evolus | Pre-clinical | 20 |
| PrabotulinumtoxinA-Xvfs + OnabotulinumtoxinA + PrabotulinumtoxinA-Xvfs | Evolus | Phase 2 | 25 |
| Botulinum toxin, Type A | Evolus | Phase 3 | 30 |
| DWP-450 (Botulinum purified neurotoxin, Type A) | Evolus | Phase 2 | 25 |
| Botulinum toxin, Type A | Evolus | Phase 3 | 30 |
| Botulinum purified neurotoxin, Type A | Evolus | Phase 2 | 25 |
| prabotulinumtoxinA | Evolus | Phase 1 | 19 |